We found that both CD24 and CD47 were overexpressed in cervical cancers, and high CD24 expression predicted a worse prognosis in both TCGA and FUSCC cohorts while CD47 expression did not show significant predictive ability in either cohort. This evidence concerns the gene CD24 and cervical cancer.